About Athos Therapeutics
Athos Therapeutics is a private company based in Torrance, California. It has reported $38,255,720 raised in three offerings on Form D since September 2021. Its chief executive is Dimitrios Iliopoulos.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | May 15, 2026 | $10,282,887of $20.0M target | 40 | $257K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 22, 2024 | Feb 6, 2024 | $7,556,334of $34.9M target | 30 | $251K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 15, 2021 | Sep 28, 2021amended Nov 17, 2021 | $20,416,499fully sold | 103 | $198K | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $38,255,720 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Athos Therapeutics's Form D filed May 15, 2026.
